A Cavoy, B Van Golf-Racht, J Delacour
Index: Pharmacol. Biochem. Behav. 47(2) , 283-7, (1994)
Full Text: HTML
Cognition-enhancing effects of no-otropic drugs are currently ascribed to an increase in arousal level. In order to test this hypothesis, we studied the effects of three doses of oxiracetam (25, 50 and 100 mg/kg IP) on a radial maze task and on slow wave sleep (SWS) latency in a familiar environment. The 25- and 100-mg/kg doses, but not the 50-mg/kg, significantly improved performance in the memory task. On the other hand, SWS latency was significantly increased by 50 and 100 mg/kg, with the effect of the 25-mg/kg dose going in the same direction but only approaching significance. These results give only a partial support to the "arousal factor hypothesis." Other factors are probably involved in the promnesic effects of oxiracetam.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Oxiracetam
CAS:62613-82-5 |
C6H10N2O3 |
|
Minaprine, but not oxiracetam, prevents desipramine-induced ...
1995-01-01 [Pol. J. Pharmacol. 47(1) , 69-73, (1995)] |
|
Pre- and postprandial pyridostigmine and oxiracetam effects ...
1996-10-01 [Psychoneuroendocrinology 21(7) , 621-9, (1996)] |
|
Putative cognition enhancers reverse kynurenic acid antagoni...
1995-01-16 [Eur. J. Pharmacol. 272(2-3) , 203-9, (1995)] |
|
Enhancement of contextual fear-conditioning by putative (+/-...
1997-09-12 [Brain Res. 768(1-2) , 197-207, (1997)] |
|
Effect of alaptide, its analogues and oxiracetam on memory f...
1996-10-24 [Eur. J. Pharmacol. 314(1-2) , 1-7, (1996)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
